Article: BUSINESS WIRE DAILY SUMMARY - AUG 29-31, 2009.

A summary of news releases for August 29, 30, and 31, 2009 compiled by Business Wire, the global leader in news distribution. To view any of these news releases on Business Wire's website, please go to www.businesswire.com.

1) Category Code: Pharmaceutical

GROUNDBREAKING RESULTS IN THE RE-LY TRIAL - NOVEL ORAL DIRECT THROMBIN INHIBITOR DABIGATRAN ETEXILATE CONVINCINGLY BEATS WARFARIN - SUPERIOR STROKE REDUCTION WITH LESS BLEEDING!

Boehringer Ingelheim today announced data from the landmark RE-LY study - the largest atrial fibrillation (AF) outcomes trial ever conducted (18,113 patients in 44 countries worldwide) - presented for the first time ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!